GlaxoSmithKline Fined for Misleading Advertising

| About: GlaxoSmithKline (GSK)

According to an article by Reuters, GlaxoSmithKline (NYSE:GSK), which trades on the New York Stock Exchange, was fined for mis-informing the public about the true content of vitamin C in its drink, Ribena, a non-carbonated soft drink made with black currant juice.

The report stated that two New Zealand schoolgirls discovered the lack of vitamin C, and after they reported it, the NZ court fined the company over $160,000 for misleading advertising.

About this article:

Expand
Tagged: , Drug Manufacturers - Major, United Kingdom
Want to share your opinion on this article? Add a comment.
Disagree with this article? .
To report a factual error in this article, click here